Flow cytometry interference in patients treated with tafasitamab: Unraveling the diagnostic maze

Fuente: Wiley Open Access
Salvato in:
Dettagli Bibliografici
Autori principali: Lisa Proost, Stijn Lambrecht, Mattias Hofmans, Ciel De Vriendt, Marijn Speeckaert, Carolien Bonroy, Barbara Denys, Sander De Bruyne
Natura: Artículo Open Access
Pubblicazione: Wiley 2024
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1867010795780440065
author Lisa Proost
Stijn Lambrecht
Mattias Hofmans
Ciel De Vriendt
Marijn Speeckaert
Carolien Bonroy
Barbara Denys
Sander De Bruyne
author_facet Lisa Proost
Stijn Lambrecht
Mattias Hofmans
Ciel De Vriendt
Marijn Speeckaert
Carolien Bonroy
Barbara Denys
Sander De Bruyne
Lisa Proost
Stijn Lambrecht
Mattias Hofmans
Ciel De Vriendt
Marijn Speeckaert
Carolien Bonroy
Barbara Denys
Sander De Bruyne
collection Wiley Open Access
contents Flow cytometry interference in patients treated with tafasitamab: Unraveling the diagnostic maze Lisa Proost Stijn Lambrecht Mattias Hofmans Ciel De Vriendt Marijn Speeckaert Carolien Bonroy Barbara Denys Sander De Bruyne HemaSphere 10.1002/hem3.39 http://creativecommons.org/licenses/by-nc-nd/4.0/
doi_str_mv 10.1002/hem3.39
format Artículo Open Access
id wiley_oa_10_1002_hem3_39
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Flow cytometry interference in patients treated with tafasitamab: Unraveling the diagnostic maze
Lisa Proost
Stijn Lambrecht
Mattias Hofmans
Ciel De Vriendt
Marijn Speeckaert
Carolien Bonroy
Barbara Denys
Sander De Bruyne
HemaSphere
Flow cytometry interference in patients treated with tafasitamab: Unraveling the diagnostic maze Lisa Proost Stijn Lambrecht Mattias Hofmans Ciel De Vriendt Marijn Speeckaert Carolien Bonroy Barbara Denys Sander De Bruyne HemaSphere 10.1002/hem3.39 http://creativecommons.org/licenses/by-nc-nd/4.0/
title Flow cytometry interference in patients treated with tafasitamab: Unraveling the diagnostic maze
topic HemaSphere
url https://onlinelibrary.wiley.com/doi/10.1002/hem3.39